Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,436.85
(
-0.86%
)
US TECH 100
28,444.80
(
-1.20%
)
Dow Jones
49,738.90
(
-0.65%
)
Brent Oil
106.31
(
2.04%
)
Bitcoin
79,070.32
(
-2.45%
)
News Focus
News Focus
Post# of 257568
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122984
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mouton29 post# 115960

Saturday, 08/27/2011 6:14:32 AM

Saturday, August 27, 2011 6:14:32 AM

Post# of 257568
Another instance where a judge blocked the launch of a generic drug pending the outcome of patent litigation: the Galderma* vs Mylan suit with respect to Oracea.

*State University of New York, Galderma’s licensor, is also a plaintiff.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today